<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="bjh15394-fig-0002" orientation="portrait" position="float">
 <label>Figure 2</label>
 <caption>
  <p>Increasing depth of response with increasing duration of therapy in response‐evaluable patients treated at the recommended phase 2 dose (modified intent‐to‐treat population). 
   <styled-content style="fixed-case">CR</styled-content>, complete response; 
   <styled-content style="fixed-case">ORR</styled-content>, overall response rate; 
   <styled-content style="fixed-case">PR</styled-content>, partial response; 
   <styled-content style="fixed-case">sCR</styled-content>, stringent complete response; 
   <styled-content style="fixed-case">VGPR</styled-content>, very good partial response.
  </p>
 </caption>
 <graphic id="nlm-graphic-3" xlink:href="BJH-182-231-g002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
